• One Health
  • Pain Management
  • Anesthesia
  • Geriatric & Palliative Medicine
  • Ophthalmology
  • Pathology
  • Infectious Diseases
  • Dermatology
  • Theriogenology
  • Animal Welfare
  • Radiology
  • Internal Medicine
  • Dentistry
  • Feline Medicine
  • Surgery
  • Avian & Exotic
  • Preventive Medicine
  • Anesthesiology & Pain Management
  • Integrative & Holistic Medicine
  • Behavior
  • Zoo Medicine
  • Toxicology
  • Orthopedics
  • Emergency & Critical Care
  • Equine Medicine
  • Pharmacology
  • Pediatrics
  • Parasitology
  • Clinical Pathology
  • Rehabilitation
  • Epidemiology
  • Aquatic Medicine
  • Livestock

Millions of NexGard PLUS doses donated to shelters in need

News
Article

The medication will help protect dogs in the chosen shelter’s protection from fleas, and ticks, prevent heartworm disease, and more.

Creative Cat Studio/stock.adobe.com

Creative Cat Studio/stock.adobe.com

The Boehringer Ingelheim Cares Foundation (BI Cares), an independent nonprofit organization, announced that through its Product Donation Program, it was able to donate 1.9 million doses of NexGard PLUS Chews to shelter dogs in need.

According to the organizational release, BI Cares partnered with Greater Good Charities to distribute these medications, worth $42.6 million to animal shelters in need.1 According to the UC Davis Koret Shelter Medicine Program, fleas are the most common external parasite found in animal shelters. As pets enter the shelters from areas that put them at high risk, such as coming off of the street, they may already be infected and become a risk to the others at the shelter.2

"Boehringer Ingelheim is deeply committed to safeguarding the health and wellbeing of animals in shelters," said Randolph Legg, president and Head of Commercial Business, Boehringer Ingelheim Animal Health USA and board member of the Boehringer Ingelheim Cares Foundation. "Our mission is to ensure they receive the best care possible while they patiently wait for their forever homes. This donation is a testament to our commitment, and we hope it will make a significant difference in the lives of animals in need."1

NexGard PLUS, an afoxolaner, moxidectin, and pyrantel chewable tablet that protects canines from fleas, ticks, heartworm disease, roundworms, and hookworms, received FDA approval in 2023. These monthly beef-flavored chews combine internal and external parasite protection to help promote adherence.3

"NexGard PLUS is the one veterinarians will want to help keep dogs protected from parasites. It offers internal and external parasite protection in a single monthly chew that dogs will enjoy, is backed by our clinic support team, and is the latest innovation in our trusted parasiticide portfolio,” said Whit Cothern, DVM, executive director of veterinary professional services at Boehringer Ingelheim Animal Health, at the time of the approval.3 “Veterinarians tackle complex challenges in their clinics every day, so we are proud to offer the solutions you want and the customer care that you want — all in one place.”

The donation provided by BI Cares will help shelter animals by giving them a product that can protect them from harmful parasites. When these pets are kept healthy and parasite-free, they have a better chance of finding their forever homes.

References

  1. 1.9 Million doses of NexGard PLUS (afoxolaner, moxidectin and pyrantel chewable tablets): Donated by Boehringer Ingelheim Cares Foundation to Aid Shelter Dogs in Need. News release. Boehringer Ingelheim. March 15, 2024. Accessed March 19, 2024. https://prnmedia.prnewswire.com/news-releases/1-9-million-doses-of-nexgard-plus-afoxolaner-moxidectin-and-pyrantel-chewable-tablets-donated-by-boehringer-ingelheim-cares-foundation-to-aid-shelter-dogs-in-need-302089861.html
  2. Flea Treatment in Animal Shelters. News release. UC Davis Koret Shelter Medicine Program. July 25, 2015. Accessed March 19, 2024. https://www.sheltermedicine.com/library/resources/flea-treatment-in-animal-shelters
  3. Crossley K. Chewable tablet receives FDA approval for internal and external parasites in dogs. Published online July 20, 2023. Accessed March 19, 2024. https://www.dvm360.com/view/chewable-tablet-receives-fda-approval-for-internal-and-external-parasites-in-dogs
Related Videos
Image Credit: © Przemyslaw Iciak - stock.adobe.com
Renee Schmid, DVM
Senior Bernese Mountain dog
merck leptospirosis panel
merck leptospirosis panel
merck leptospirosis panel
© 2024 MJH Life Sciences

All rights reserved.